Zelluna ASA Calls Extraordinary Meeting; Proposes New Biotech Leader for Board as Member Departs

Zelluna ASA (OSE: ZLNA) has called an Extraordinary General Meeting (EGM) for 9 September 2026 at 13:00 CEST, according to GlobeNewswire. The meeting has one item on the agenda: electing a new member to the Board of Directors after a current member steps down.
The Nomination Committee has proposed Martin Welschof as the incoming board member, according to Yahoo Finance. Welschof is CEO of BioInvent, a Swedish biotech company, and brings broad international experience in the sector.
The Nomination Committee selected Martin Welschof as its candidate for the open board position, according to Market Screener. Welschof currently serves as CEO of BioInvent, a clinical-stage biotech firm. His international background in drug development and company leadership was cited as a key reason for the nomination.
Zelluna is a Norwegian cell therapy company listed on the Oslo Stock Exchange. Adding an experienced biotech executive to its board signals a push for stronger strategic leadership as the company advances its programs, according to GlobeNewswire.
A current board member is stepping down, which triggered the need for an extraordinary meeting rather than waiting for the next annual general meeting. Norwegian company law requires shareholder approval to elect new board members. The EGM on 9 September gives shareholders a direct vote on Welschof's appointment, according to Yahoo Finance.
Holding an EGM is a faster path than waiting months for a regular annual meeting. It shows Zelluna's board wants to fill the seat quickly and keep its governance structure intact, according to GlobeNewswire.
The meeting is set for 9 September 2026 at 13:00 CEST. Shareholders who want to vote can do so in person or by proxy. The single agenda item is the election of a new board member. No other business is scheduled, according to Market Screener.
If approved, Welschof will join the board immediately after the vote. His term length and any compensation details were not disclosed in the notice, according to Yahoo Finance.
Publishers
4
Articles
4
Reach
5